Assessment of frequency and severity of hypomagnesemia in patients with metastatic colorectal cancer treated with cetuximab, with a review of the literature

Currently, there are a few systemic treatment options for patients with metastatic colorectal cancer (mCRC). Targeted therapy used in this setting includes the use of monoclonal antibodies, such as cetuximab or panitumumab, directed against epidermal growth factor receptor. The aim of the present st...

Disgrifiad llawn

Wedi'i Gadw mewn:
Manylion Llyfryddiaeth
Cyhoeddwyd yn:Oncol Lett
Prif Awduron: STREB, JOANNA, PÜSKÜLLÜOĞLU, MIROSLAWA, GLANOWSKA, IZABELA, OCHENDUSZKO, SEBASTIAN, KONOPKA, KAMIL, ŁUPKOWSKI, RADOSLAW, MICHALOWSKA-KACZMARCZYK, ANNA, BOCHENEK-CIBOR, JUSTYNA, MAJKA, MARCIN, KRZEMIENIECKI, KRZYSZTOF
Fformat: Artigo
Iaith:Inglês
Cyhoeddwyd: D.A. Spandidos 2015
Pynciau:
Articles
Mynediad Ar-lein:https://ncbi.nlm.nih.gov/pmc/articles/PMC4665193/
https://ncbi.nlm.nih.gov/pubmed/26788202
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3892/ol.2015.3800
Tagiau: Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!

Eitemau Tebyg